Game-changer drug is the first to tackle overeating in Prader-Willi syndrome A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.

https://www.drugdiscoverynews.com/game-changer-drug-is-the-first-to-tackle-overeating-in-prader-willi-syndrome-16355?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-86yGH-Ifq2Mz8C63AlCp52AfccMtQMxMv-jlSmcIV-aCTiX9MycX7lZE82yolOqTlkJQsowhyz88yTiXp8BKfFCziIfQ&_hsmi=377989063&utm_content=377989063&utm_source=hs_email